Core stocks generate reliable and growing returns for you and your portfolio. Here are five core stocks we like for the long ...

The Mid-West of Ireland has a deserved reputation as a location for globally recognised companies to set up and expand operations. In the past five years alone, billions of euro in foreign direct ...

Meet the lawyers who earn billions on pelvic-mesh injuries while their clients get the scraps.

Boston Scientific announced it has received CE Mark approval for the company’s Embold detachable coil system, which is a ...

Boston Scientific (NYSE: BSX) announced that it received CE mark approval for its Embold detachable coil system.

Boston Scientific has told customers to stop using certain stents linked to three deaths, the Food and Drug Administration ...

Penumbra is expected to give Boston Scientific more of a presence in the vascular surgery market, with little overlap between ...

Boston Scientific Corp.’s intent to acquire Penumbra Inc. for $14.5 billion will not only allow it to expand its minimal ...

Boston Scientific is buying up privately owned medtech Valencia Technologies for its implantable device aimed at helping ...

Boston Scientific is recommended as a buy with a $109 target price, implying 14% upside, driven by robust demand and niche leadership. BSX outpaces market growth through focused M&A, strong execution ...

Boston Scientific is purchasing heart-device company Penumbra for roughly $14.5 billion in cash and stock, marking the largest deal in two decades for the medtech company with a large Minnesota ...

Boston Scientific (BSX) closed the most recent trading day at $97.79, moving +2.42% from the previous trading session. This change outpaced the S&P 500's 0.62% gain on the day. On the other hand, the ...